ADVERTISEMENT

Biocon Biologics' IPO Within Next 2 Years, Says Kiran Mazumdar-Shaw

NDTV Profit
Biocon Biologics will file for an IPO within the next two years
Biocon Biologics, a subsidiary of Biocon, will file for an initial public offer (IPO) within the next two years, executive chairperson Kiran Mazumdar-Shaw said on Monday.
Register for Free
to continue reading
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit